LDTI (Proteo Biotech)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameLDTI (Proteo Biotech)
Drug Alias Nameleech-derived tryptase inhibitor (Proteo Biotech)LDTI
ClassificationBiologics > Protein drugs > Recombinant proteinNatural product/Extract
Mechanisms of ActionTryptase inhibitors
TargetsTryptase
Therapy Area/IndicationsInflammationCicatrix
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companiestiakis Biotech AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companiestiakis Biotech AG
Active IndicationsN/A
Inactive IndicationsInflammationCicatrix

Other Information

ATC CodeN/A
Related LinksN/A